136 — China Ruyi Holdings — closes the week with a borrow market approaching its annual floor, a stock down 16% in five sessions, and a short score that refuses to break lower even as shorts trim.
The structural story in the lending market has deteriorated further since the last note filed earlier today. Availability has tightened to just 8% — one share left to lend for every twelve already borrowed — compared with roughly 21% a week ago. The 52-week low is 7.5%, meaning the lending pool is within a whisker of its tightest point of the past year. Cost to borrow has pulled back sharply from the 105% spike on August 26, landing at 23% on September 1. That retreat is not a sign of ease. It reflects partial short covering — short interest fell nearly 5% on the week — which reduced the frantic competition for scarce supply. The pool itself has also shrunk in parallel. The net result is a market where availability is now more constrained than at any point during the August 26 crisis, even though the headline borrow rate looks calmer.
The ORTEX short score sits at 95.2 — near the top of the universe for short-side stress — and has been running between 94 and 97 for the past two weeks without a sustained break lower. That persistence matters. Even with short interest declining, the composite signal is not easing, because the tightening availability is offsetting the covering activity. The factor score picture reinforces this: days-to-cover ranks in the 5th percentile and the short score rank is effectively at zero. There is no reading in the factor data that suggests positioning comfort.
The price tells its own story. China Ruyi closed at HK$1.24 on September 1, down 7.8% on the day and 16% on the week, and off nearly 14% over the past month. What makes that move notable is the peer context. Mainland-listed comparables posted gains of 3% to 13% over the same week — the Shanghai and Shenzhen peers in the correlated basket were mostly green, with one up 13% on the week. China Ruyi is moving in the opposite direction, and doing so on an accelerating basis. The nearest Hong Kong-listed peer, 1060, also fell around 5% on the week, but the divergence versus the mainland names is stark.
Ownership has not changed materially. Tencent Holdings holds a 15.6% stake, Sunshine Insurance holds 9%, and anchor shareholder Liming Ke holds nearly 16%. None of these positions have moved in recent disclosure windows. BlackRock added around 20 million shares as of mid-August, and JPMorgan filed a buy of roughly 88 million shares in June — though that June filing represents a crossing of the 5% reporting threshold rather than a directional conviction trade. The analyst picture is stale: the sole buy-rated coverage with a HK$2.90 target was last updated in late May and should be treated as outdated given the stock has since fallen well below that level.
An earnings event appears in the history dated August 28, which produced a 6.6% single-day drop. That reaction is consistent with the prior May event, which also fell after results. The next reported event is flagged as September 2 — today — with no price reaction yet captured. That print, and any accompanying guidance or asset update from the company, is the single variable most worth watching as availability approaches its 52-week floor.
See the live data behind this article on ORTEX.
Open 136 on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
